Business Context and Reporting Period
Company: Abundia Global Impact Group, Inc. (AGIG)
Filing Type: Form 8-K (Current Report)
Reporting Date: February 19, 2026 (Event Date); February 23, 2026 (Closing Date)
Context: The Company announced and subsequently closed a registered direct offering of common stock and pre-funded warrants to a single institutional investor.
Key Financial Metrics
- Gross Proceeds: Approximately $20.0 million (before deducting placement agent fees and offering expenses).
- Securities Issued:
- 4,134,175 shares of Common Stock.
- Pre-Funded Warrants to purchase up to 1,800,543 shares of Common Stock at an exercise price of $0.001 per share.
- Placement Agent Fees:
- Cash fee: Approximately 7.0% of gross proceeds.
- Non-accountable expense allowance: 0.5% of gross proceeds.
- Placement Agent Warrants: 118,694 warrants to purchase Common Stock at 110% of the public offering price.
- Legal expense reimbursement: Up to $100,000.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these operational or balance sheet metrics.
Material Changes
This filing reports a material capital raise event rather than a change in operational performance compared to a prior period. The primary material change is the increase in outstanding share count and the receipt of gross proceeds of $20.0 million. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Restrictions
- Lock-Up Agreements: Directors, executive officers, and 5% holders agreed not to sell or transfer securities for 75 days following the closing date.
- Issuance Restrictions: The Company is restricted from issuing or selling Common Stock or Common Stock Equivalents for 75 days following the closing.
- Beneficial Ownership Limits: Holders of Pre-Funded Warrants are subject to beneficial ownership limitations (initially 4.99% or 9.99%, up to a maximum of 19.99% with notice).
- Management Commentary: The filing does not contain specific forward-looking guidance or management commentary regarding future business strategy beyond the transaction details.
Investor Verification Checklist
- Verify the net proceeds after deducting the 7.5% cash fees and legal expenses.
- Confirm the exact public offering price per share to calculate the exercise price of the Placement Agent Warrants (110% of offering price).
- Review the full text of the Securities Purchase Agreement (Exhibit 10.2) for specific covenants and representations.
- Check the Company's updated capitalization table to assess the dilution impact of the 4,134,175 new shares and 1,800,543 pre-funded warrants.
- Monitor the 75-day lock-up expiration date for potential selling pressure from insiders.